Vaccine Design, Development, and Delivery
A section of Vaccines (ISSN 2076-393X).
Keywords
- adjuvants
- mucosal vaccines
- immune mechanisms driven by adjuvants
Editorial Board
Topical Advisory Panel
Click here to see the Section Topical Advisory Panel of "Vaccine Design, Development, and Delivery".
Special Issues
Following special issues within this section are currently open for submissions:
- Virus-Like Particle (VLP) Vaccines Against Emerging Infectious Diseases—2nd Edition (Deadline: 30 September 2025)
- Research in Vaccine Adjuvants: Innovations and Challenges (Deadline: 31 October 2025)
- Nanomaterial Application in Vaccines (Deadline: 31 October 2025)
- Advances in the Use of Nanoparticles for Vaccine Platform Development: 2nd Edition (Deadline: 30 November 2025)
- Recent Advances in Virus-Like Particle-Based Vaccines (Deadline: 31 December 2025)
- Innovations in Vaccine Technology (Deadline: 31 January 2026)
- Advances in Vaccine Adjuvants (Deadline: 31 January 2026)
- Nanoparticle-Based Delivery Systems for Vaccines (Deadline: 28 February 2026)
- Applications of Nanoparticles in Vaccines (Deadline: 28 February 2026)
- Mucosal Vaccines: Advances in Technology and Delivery (Deadline: 28 February 2026)
- Novel Adjuvants and Delivery Systems for Vaccines (Deadline: 31 March 2026)
- Novel Vaccine Designs to Enhance the Engagement of Innate and Adaptive Immunity (Deadline: 30 April 2026)
- Novel Adjuvants and Delivery Technologies for Vaccine Development (Deadline: 31 May 2026)
- Recent Research on Adenovirus-Vectored Vaccines (Deadline: 31 May 2026)
- Immune Imprinting: Effects, Mechanisms, and Implications for Vaccine Design (Deadline: 30 June 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
